Literature DB >> 35355704

Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis.

Huiying Xu1, Ruidong Liu2, Yanli Lv1, Zhenhua Fan3, Weimin Mu1, Qingzhong Yang1, Hui Fu1, Yi Li1.   

Abstract

Introduction: Periductal mastitis (PDM) is a complex benign breast disease with a prolonged course and a high risk of recurrence after treatment. There are many available treatments for PDM, but none is widely accepted. This study aims to evaluate the various treatment failure rates (TFR) of different invasive treatment measures by looking at recurrence and persistence after treatment. In this way, it sets out to inform better clinical decisions in the treatment of PDM.
Methods: We searched PubMed, Embase, and Cochrane Library databases for eligible studies about different treatment regimens provided to PDM patients that had been published before October 1, 2019. We included original studies written in English that reported the recurrence and/or persistence rates of each therapy. Outcomes were presented as pooled TFR and 95% CI for the TFR.
Results: We included 27 eligible studies involving 1,066 patients in this study. We summarized 4 groups and 10 subgroups of PDM treatments, according to the published studies. Patients treated minimally invasively (group 1) were subdivided into 3 subgroups and pooled TFR were calculated as follows: incision and drainage (n = 73; TFR = 75.6%; 95% CI 27.3-100%), incision alone (n = 74; TFR = 20.1%; 95% CI 0-59.9%), and breast duct irrigation (n = 123; TFR = 19.4%; 95% CI 0-65.0%). Patients treated with a minor excision (excision of the infected tissue and related duct; group 2) were divided into 4 subgroups and pooled TFR were calculated as follows: wound packing alone (n = 127; TFR = 2.1%; 95% CI 0-5.2%), primary closure alone (n = 66; TFR = 37.1%; 95% CI 9.5-64.8%), primary closure under antibiotic treatment cover (n = 55; TFR = 4.8%; 95% CI 0-11.4%), and additional nipple part removal (n = 232; TFR = 9.6%; 95% CI 5.8-13.4%). Patients treated with a major excision (excision of the infected tissue and the major duct; group 3) included the following 2 subgroups: patients treated with a circumareolar incision (n = 142; TFR = 7.5%; 95% CI 0.4-14.7%) and patients treated with a radial incision of the breast (n = 78; TFR = 0.6%; 95% CI 0-3.6%). Group 4 contained patients receiving different major plastic surgeries. The pooled TFR of this group (n = 86) was 3.4% (95% CI 0-7.5%).
Conclusion: Breast duct irrigation, which is the most minimally invasive of all of the treatment options, seemed to yield good outcomes and may be the first-line treatment for PDM patients. Minor excision methods, except for primary closure alone, might be enough for most PDM patients. Major excision, especially with radial incision, was a highly effective salvage therapy. The major plastic surgery technique was also acceptable as an alternative treatment for patients with large lesions and concerns about breast appearance. Incision and drainage and minor excision with primary closure alone should be avoided for PDM patients. Further research is still needed to better understand the etiology and pathogenesis of PDM and explore more effective treatments for this disease.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Failure treatment; Meta-analysis; Periductal mastitis; Recurrence rate; Treatment

Year:  2021        PMID: 35355704      PMCID: PMC8914206          DOI: 10.1159/000514419

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  43 in total

1.  Subareolar breast abscesses: characteristics and results of surgical treatment.

Authors:  F N Lesanka Versluijs-Ossewaarde; Rudi M H Roumen; R J A Goris
Journal:  Breast J       Date:  2005 May-Jun       Impact factor: 2.431

2.  Surgical management of recurrent subareolar breast abscesses: Mayo Clinic experience.

Authors:  Sean Li; Clive S Grant; Amy Degnim; John Donohue
Journal:  Am J Surg       Date:  2006-10       Impact factor: 2.565

3.  Recurrent subareolar abscess of the breast and squamous metaplasia of the lactiferous ducts: a clinical syndrome.

Authors:  B C Powell; K I Maull; C R Sachatello
Journal:  South Med J       Date:  1977-08       Impact factor: 0.954

4.  Further experience of the operation for excision of the major duct system of the breast.

Authors:  G J Hadfield
Journal:  Br J Surg       Date:  1968-07       Impact factor: 6.939

5.  Chronic recurrent periareolar abscess secondary to inversion of the nipple.

Authors:  H T Caswell; W P Maier
Journal:  Surg Gynecol Obstet       Date:  1969-03

6.  Ductal Lavage for Patients With Nonlactational Mastitis: A Single-Arm, Proof-of-Concept Trial.

Authors:  Kai Chen; Liling Zhu; Tingting Hu; Cui Tan; Jian Zhang; Minhua Zeng; Shunrong Li; Erwei Song
Journal:  J Surg Res       Date:  2018-11-19       Impact factor: 2.192

7.  Ultrasound-guided drainage of breast abscesses: results in 151 patients.

Authors:  A F Christensen; N Al-Suliman; K R Nielsen; I Vejborg; N Severinsen; H Christensen; M B Nielsen
Journal:  Br J Radiol       Date:  2005-03       Impact factor: 3.039

8.  How mammillary fistulas should be managed.

Authors:  Satheesha Hanavadi; Gordon Pereira; Robert E Mansel
Journal:  Breast J       Date:  2005 Jul-Aug       Impact factor: 2.431

9.  Subareolar dissection for duct ectasia and periareolar sepsis.

Authors:  M N Hartley; J Stewart; E A Benson
Journal:  Br J Surg       Date:  1991-10       Impact factor: 6.939

10.  Mammillary fistula.

Authors:  N J Bundred; J M Dixon; U Chetty; A P Forrest
Journal:  Br J Surg       Date:  1987-06       Impact factor: 6.939

View more
  1 in total

1.  Diagnostic value of radiomics model based on gray-scale and contrast-enhanced ultrasound for inflammatory mass stage periductal mastitis/duct ectasia.

Authors:  Yan Zheng; Lu Bai; Jie Sun; Lin Zhu; Renjun Huang; Shaofeng Duan; Fenglin Dong; Zaixiang Tang; Yonggang Li
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.